Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Open-label Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Age With Prurigo Nodularis

NCT06293053 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT06293053
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06293053 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Open-label Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Age With Prurigo Nodularis
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Recruiting
Start date
May 15, 2024
Completion date
November 3, 2027
Enrollment
18 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

prurigo nodularis